
The civil rights leader Rev. Jesse Jackson has been hospitalized, the Rainbow PUSH Coalition announced Wednesday evening.
Jackson, 84, has been admitted to the hospital and is under observation for progressive supranuclear palsy, a neurodegenerative condition, which he has been managing for a decade, the organization said in a statement.
"The family appreciates all prayers at this time," the group said.
Jackson was originally diagnosed with Parkinson's disease, however his PSP condition was confirmed in April, the organization said.
PSP is a rare neurological disorder which affects body movements, walking and balance, and eye movements, according to the National Institutes of Health. It is caused by damage to nerve cells in parts of the brain.
Jackson, a protege to the Rev. Martin Luther King Jr. who rose to prominence as one of the nation's foremost civil rights leaders and twice ran for U.S. president, stepped down in 2023 from the leadership of the Rainbow PUSH Coalition, which he founded.
latest_posts
- 1
Instructions to Augment the Presentation of Your Kona SUV - 2
NASA shares first photos of Earth taken by Artemis II - 3
This Asian country is the next hot travel destination, and this is one of its best hotels - 4
Figure out How to Ascertain the Restitution Time frame for Your Sunlight based chargers - 5
10 times the sky amazed us in 2025
Munich Security Conference chief defends inviting AfD lawmakers
Venus shines at its best in spring and summer 2026 — here's what to look for
'We are ready': NASA still on track to launch Artemis 2 astronauts to the moon April 1
British-Egyptian dissident apologises for tweets as Tories push for UK deportation
UK consumer confidence plunges amid escalating Iran conflict
First Phosphate advances battery-grade phosphate project as analysts highlight strategic Federal support
Merz: 80% of Syrians in Germany should return in three years
5 Family SUVs for 2024: Which One Accommodates Your Family's Needs\uff1f
Lower-cost space missions like NASA's ESCAPADE are starting to deliver exciting science – but at a price in risk and trade‑offs













